PDS Biotechnology
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of PDS Biotechnology generated cash of -$33,636,136, which is less than the previous year. Cash used in financing activities reached the amount of $16,376,493 last year. Net change in cash is therefore -$17,259,643.
Cash Flow
| 2014 | -9.71M | -884.79K | 16.47M |
|---|---|---|---|
| 2015 | -21.75M | -1.30M | 139.51M |
| 2016 | -32.18M | -686.70K | 9.08M |
| 2017 | -40.69M | -188.72K | 22.55M |
| 2018 | -33.15M | 0 | -20.26M |
| 2019 | -18.07M | 29.38M | 750K |
| 2020 | -13.14M | 0 | 29.82M |
| 2021 | -12.48M | 0 | 48.88M |
| 2022 | -25.70M | 0 | 34.28M |
| 2023 | -33.63M | 0 | 16.37M |
PDSB Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 73.82M | 65.24M | 28.83M | 12.16M | 103.69K | 88.06M | 106.39M | 130.18M | 13.72M | 7.85M |
Operating activities | ||||||||||
Net income | -42.94M | -40.85M | -16.91M | -14.84M | -6.99M | -40.86M | -50.85M | -38.82M | -28.07M | -12.20M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 17.35K | 86 | 5.35K | 15.60K | 98.41K | 174.34K | 182.91K | 100.11K | 53.11K | 31.22K |
Stock-based compensation expense | 7.61M | 5.19M | 4.11M | 452.28K | 3.17M | 0 | 6.40M | 5.30M | 2.89M | 1.29M |
| Deferred income tax benefit | 7.61M | 5.19M | 4.11M | 452.28K | 3.17M | 0 | 6.40M | 5.30M | 2.89M | 1.29M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 5.76M | -90.11K | -105.82K | 217.50K | -1.97M | -3.96M | 898.10K | 1.42M | -71.75K | 526.86K |
Cash generated by operating activities | -33.63M | -25.70M | -12.48M | -13.14M | -18.07M | -33.15M | -40.69M | -32.18M | -21.75M | -9.71M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -4 | 0 | 0 | 0 | 0 | 0 | -188.72K | -686.70K | -1.30M | -884.79K |
Acquisitions Net | 0 | 0 | 0 | 0 | 29.10M | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 0 | 0 | 29.38M | 0 | -188.72K | -686.70K | -1.30M | -884.79K |
Financing activities | ||||||||||
Common Stock Issued | 16.12M | 9.85M | 48.88M | 29.75M | 750K | 0 | 17.38M | 0 | 86.05M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -59.3K | 25M | 0 | 0 | 0 | -20.99M | 5M | -1.48M | 2.46M | 0 |
Cash used in financing activities | 16.37M | 34.28M | 48.88M | 29.82M | 750K | -20.26M | 22.55M | 9.08M | 139.51M | 16.47M |
Net Change In Cash | -17.25M | 8.57M | 36.40M | 16.67M | 12.05M | -53.42M | -18.33M | -23.79M | 116.46M | 5.87M |
Cash at end of period | 56.56M | 73.82M | 65.24M | 28.83M | 12.16M | 34.64M | 88.06M | 106.39M | 130.18M | 13.72M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |